All Stories

  1. Prediabetes Increases the Risk of Frailty in Older Adults With Prefrail Hypertension: Beneficial Effects of Metformin

    Article • Hypertension, May 2024, Wolters Kluwer Health

    Gaetano Santulli

  2. Dietary Supplements in Cardiovascular and Metabolic Diseases

    Article • Nutrients, May 2024, MDPI AG

    Gaetano Santulli

  3. Time to negative conversion and cardiopulmonary performance in COVID-19 athletes

    Article • ERJ Open Research, March 2024, European Respiratory Society (ERS)

    Gaetano Santulli

  4. Leukocytes and Endothelial Cells Participate in the Pathogenesis of Alzheimer’s Disease: Identifying New Biomarkers Mirroring Metabolic Alterations

    Article • Journal of Alzheimer s Disease, January 2024, IOS Press

    Gaetano Santulli

  5. Interleukin-1 receptor associated kinase 2 is a functional downstream regulator of complement factor D that controls mitochondrial fitness in diabetic cardiomyopathy

    Article • Military Medical Research, January 2024, Springer Science + Business Media

    Gaetano Santulli

  6. Effects of moderate caffeine intake in athletes

    Article • European Journal of Internal Medicine, January 2024, Elsevier

    Gaetano Santulli

  7. Complete or Culprit-Only PCI in Older Patients with MI

    Article • New England Journal of Medicine, November 2023, New England Journal of Medicine (NEJM/MMS)

    Gaetano Santulli

  8. Infiltrating macrophages amplify doxorubicin-induced cardiac damage: role of catecholamines

    Article • Cellular and Molecular Life Sciences, October 2023, Springer Science + Business Media

    Gaetano Santulli

  9. Cardiac Sarcoidosis: Updated Insights on Epidemiology and Diagnostic Criteria

    Article • The American Journal of Cardiology, October 2023, Elsevier

    Gaetano Santulli

  10. Re: Differential benefits of physical training associated or not with L-Arginine supplementation in rats with metabolic syndrome: Evaluation of cardiovascular, autonomic and metabolic parameters

    Article • Physiology & Behavior, October 2023, Elsevier

    Gaetano Santulli

  11. Functional Role of Taurine in Aging and Cardiovascular Health: An Updated Overview

    Article • Nutrients, September 2023, MDPI AG

    Gaetano Santulli

  12. Mitochondrial Calcium Overload Plays a Causal Role in Oxidative Stress in the Failing Heart

    Article • Biomolecules, September 2023, MDPI AG

    Gaetano Santulli, Gunnar Weninger

  13. SGLT2 inhibitors: an evidence-based update on cardiovascular implications

    Article • Expert Opinion on Investigational Drugs, September 2023, Taylor & Francis

    Gaetano Santulli

  14. Functional and Clinical Importance of SGLT2-inhibitors in Frailty: From the Kidney to the Heart

    Article • Hypertension, September 2023, Wolters Kluwer Health

    Gaetano Santulli

  15. Ketone Bodies Rescue Mitochondrial Dysfunction Via Epigenetic Remodeling

    Article • JACC Basic to Translational Science, September 2023, Elsevier

    Gaetano Santulli

  16. Editorial: Influence of lifestyle factors in the management of diabetes mellitus

    Article • Frontiers in Endocrinology, August 2023, Frontiers

    Gaetano Santulli

  17. Editorial: Wnt signaling in endocrine and metabolic disorders

    Article • Frontiers in Endocrinology, August 2023, Frontiers

    Gaetano Santulli

  18. Editorial: Insights in cardiovascular endocrinology: 2023

    Article • Frontiers in Endocrinology, August 2023, Frontiers

    Gaetano Santulli

  19. Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque

    Article • Atherosclerosis, August 2023, Elsevier

    Gaetano Santulli

  20. Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry

    Article • Diabetes Research and Clinical Practice, August 2023, Elsevier

    Gaetano Santulli

  21. Editorial: Mitochondrial remodeling and dynamic inter-organellar contacts in cardiovascular physiopathology-Volume II

    Article • Frontiers in Cell and Developmental Biology, June 2023, Frontiers

    Gaetano Santulli

  22. Editorial: The link between obesity, type 2 diabetes, and mitochondria

    Article • Frontiers in Endocrinology, June 2023, Frontiers

    Gaetano Santulli

  23. miR-181c targets Parkin and SMAD7 in human cardiac fibroblasts: Validation of differential microRNA expression in patients with diabetes and heart failure with preserved ejection fraction

    Article • Mechanisms of Ageing and Development, June 2023, Elsevier

    Gaetano Santulli

  24. Insulin resistance drives cognitive impairment in hypertensive pre-diabetic frail elders: the CENTENNIAL study

    Article • European Journal of Preventive Cardiology, May 2023, Oxford University Press (OUP)

    Gaetano Santulli

  25. Molecular Mechanisms Underlying Pluripotency and Self-Renewal of Embryonic Stem Cells

    Article • International Journal of Molecular Sciences, May 2023, MDPI AG

    Gaetano Santulli

  26. The therapeutic concordance approach reduces adverse drug reactions in patients with resistant hypertension

    Article • Frontiers in Cardiovascular Medicine, May 2023, Frontiers

    Gaetano Santulli

  27. Beneficial effects of L-Arginine in patients hospitalized for COVID-19: New insights from a randomized clinical trial

    Article • Pharmacological Research, May 2023, Elsevier

    Gaetano Santulli

  28. Translational Aspects of Cardiovascular Biology: From Bench to Bedside

    Article • Biology, April 2023, MDPI AG

    Gaetano Santulli

  29. Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in Diabetic patients with Acute Myocardial Infarction: Insight from SGLT2-I AMI PROTECT Registry

    Article • April 2023, Research Square

    Gaetano Santulli

  30. A machine learning model identifies a functional connectome signature that predicts blood pressure levels: imaging insights from a large population of 35882 patients

    Article • Cardiovascular Research, April 2023, Oxford University Press (OUP)

    Gaetano Santulli

  31. Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study

    Article • Cardiovascular Diabetology, April 2023, Springer Science + Business Media

    Gaetano Santulli

  32. A novel urinary proteomic classifier predicts the risk of coronary artery disease

    Article • European Journal of Preventive Cardiology, April 2023, Oxford University Press (OUP)

    Gaetano Santulli

  33. L-Arginine in diabetes: clinical and preclinical evidence

    Article • Cardiovascular Diabetology, April 2023, Springer Science + Business Media

    Gaetano Santulli

  34. miR-4432 Targets FGFBP1 in Human Endothelial Cells

    Article • Biology, March 2023, MDPI AG

    Gaetano Santulli

  35. Editorial: Methods and applications in clinical and translational physiology

    Article • Frontiers in Physiology, March 2023, Frontiers

    Gaetano Santulli

  36. Choline supplements: An update

    Article • Frontiers in Endocrinology, March 2023, Frontiers

    Gaetano Santulli

  37. Experimental evidence and clinical implications of Warburg effect in the skeletal muscle of Fabry disease

    Article • iScience, March 2023, Elsevier

    Gaetano Santulli

  38. Reply to SGLT-2 inhibitors: Post-infarction interventional effects

    Article • Pharmacological Research, March 2023, Elsevier

    Gaetano Santulli

  39. Editorial: Transcription factors and arrhythmogenesis

    Article • Frontiers in Physiology, February 2023, Frontiers

    Gaetano Santulli

  40. COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells

    Article • Antioxidants, January 2023, MDPI AG

    Gaetano Santulli

  41. Endothelial Dysfunction Drives CRTd Outcome at 1-Year Follow-Up: A Novel Role as Biomarker for miR-130a-5p

    Article • International Journal of Molecular Sciences, January 2023, MDPI AG

    Gaetano Santulli

  42. Hyperglycemia drives the transition from pre-frailty to frailty: The Monteforte study

    Article • European Journal of Internal Medicine, January 2023, Elsevier

    Gaetano Santulli

  43. Linking lifestyle factors to cardiovascular risk through metabolomics: Insights from a large population of diabetic patients followed-up for 11 years

    Article • Atherosclerosis, January 2023, Elsevier

    Gaetano Santulli

  44. Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry

    Article • Pharmacological Research, January 2023, Elsevier

    Gaetano Santulli

  45. Therapeutic concordance improves blood pressure control in patients with resistant hypertension

    Article • Pharmacological Research, January 2023, Elsevier

    Gaetano Santulli

  46. Istaroxime and Beyond: New Therapeutic Strategies to Specifically Activate SERCA and Treat Heart Failure

    Article • Journal of Pharmacology and Experimental Therapeutics, December 2022, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Gaetano Santulli

  47. Non-Coding RNAs in Clinical Practice: From Biomarkers to Therapeutic Tools

    Article • Journal of Pharmacology and Experimental Therapeutics, December 2022, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Gaetano Santulli

  48. Sortilin and hypertension

    Article • Current Opinion in Nephrology & Hypertension, December 2022, Wolters Kluwer Health

    Gaetano Santulli

  49. Aprocitentan: New insights

    Article • Frontiers in Cardiovascular Medicine, December 2022, Frontiers

    Gaetano Santulli

  50. Targeting Cardiovascular and Metabolic Disorders Through Annual Nationwide Screening and Lifestyle Intervention: Insights from a Cohort of 5,819,041 Subjects with a 4-year Follow-up

    Article • European Journal of Preventive Cardiology, December 2022, Oxford University Press (OUP)

    Gaetano Santulli

  51. Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure

    Article • Journal of Clinical Medicine, December 2022, MDPI AG

    Gaetano Santulli

  52. The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension

    Article • Frontiers in Endocrinology, December 2022, Frontiers

    Gaetano Santulli

  53. Stress Hyperglycemia Drives the Risk of Hospitalization for Chest Pain in Patients With Ischemia and Nonobstructive Coronary Arteries (INOCA)

    Article • Diabetes Care, December 2022, American Diabetes Association

    Gaetano Santulli

  54. Tirzepatide: A Systematic Update

    Article • International Journal of Molecular Sciences, November 2022, MDPI AG

    Gaetano Santulli

  55. Beneficial effects of Vitamin C and L-Arginine in the treatment of post-acute sequelae of COVID-19

    Article • Pharmacological Research, November 2022, Elsevier

    Gaetano Santulli

  56. Endothelial dysfunction in long-COVID: New insights from the nationwide multicenter LINCOLN Study

    Article • Pharmacological Research, November 2022, Elsevier

    Gaetano Santulli

  57. High HDL (High-Density Lipoprotein) Cholesterol Increases Cardiovascular Risk in Hypertensive Patients

    Article • Hypertension, October 2022, Wolters Kluwer Health

    Gaetano Santulli

  58. Targeting endothelial dysfunction and oxidative stress in Long-COVID

    Article • Pharmacological Research, October 2022, Elsevier

    Gaetano Santulli

  59. In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study

    Article • Frontiers in Cardiovascular Medicine, September 2022, Frontiers

    Gaetano Santulli

  60. Empagliflozin and Cognitive Impairment in Frail Older Adults with Type 2 Diabetes and Heart Failure

    Article • Diabetes Care, September 2022, American Diabetes Association

    Gaetano Santulli

  61. miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections

    Article • International Journal of Molecular Sciences, September 2022, MDPI AG

    Gaetano Santulli

  62. Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey

    Article • Pharmacological Research, September 2022, Elsevier

    Gaetano Santulli

  63. Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.”

    Article • EClinicalMedicine, September 2022, Elsevier

    Gaetano Santulli

  64. SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients

    Article • Hypertension, August 2022, Wolters Kluwer Health

    Gaetano Santulli

  65. Parkin Controls Cardiac Function in Obesity by Regulating Mitochondrial Calcium Uptake

    Article • JACC Basic to Translational Science, August 2022, Elsevier

    Gaetano Santulli

  66. From resveratrol to ISIDE11: how to activate SIRT1 and improve endothelial function? New therapeutic insights for methylenetetrahydrofolate reductase deficiency

    Article • Cellular and Molecular Life Sciences, July 2022, Springer Science + Business Media

    Gaetano Santulli

  67. Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes

    Article • Journal of Pharmacology and Experimental Therapeutics, July 2022, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Gaetano Santulli

  68. Functional role of miR-34a in diabetes and frailty

    Article • Frontiers in Aging, July 2022, Frontiers

    Gaetano Santulli

  69. Nogo-A reduces ceramide de novo biosynthesis to protect from heart failure

    Article • Cardiovascular Research, July 2022, Oxford University Press (OUP)

    Gaetano Santulli

  70. Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19

    Article • Journal of Pharmacology and Experimental Therapeutics, June 2022, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Gaetano Santulli

  71. Mitochondrial microRNAs are dysregulated in patients with Fabry Disease

    Article • Journal of Pharmacology and Experimental Therapeutics, June 2022, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Gaetano Santulli

  72. Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry

    Article • Cardiovascular Diabetology, May 2022, Springer Science + Business Media

    Gaetano Santulli

  73. The Non-Coding RNA Journal Club: Highlights on Recent Papers—11

    Article • Non-Coding RNA, May 2022, MDPI AG

    Gaetano Santulli

  74. Physical decline and cognitive impairment in frail hypertensive elders during COVID-19

    Article • European Journal of Internal Medicine, May 2022, Elsevier

    Gaetano Santulli

  75. Hyperglycemia and Physical Impairment in Frail Hypertensive Older Adults

    Article • Frontiers in Endocrinology, April 2022, Frontiers

    Gaetano Santulli

  76. Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis

    Article • Frontiers in Cardiovascular Medicine, April 2022, Frontiers

    Gaetano Santulli

  77. L-Arginine Improves Cognitive Impairment in Hypertensive Frail Older Adults

    Article • Frontiers in Cardiovascular Medicine, April 2022, Frontiers

    Gaetano Santulli

  78. Bioengineering Strategies to Create 3D Cardiac Constructs from Human Induced Pluripotent Stem Cells

    Article • Bioengineering, April 2022, MDPI AG

    Gaetano Santulli

  79. L-Arginine Enhances the Effects of Cardiac Rehabilitation on Physical Performance: New Insights for Managing Cardiovascular Patients During the COVID-19 Pandemic

    Article • Journal of Pharmacology and Experimental Therapeutics, March 2022, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Gaetano Santulli

  80. Omega-3 fatty acids coordinate glucose and lipid metabolism in diabetic patients

    Article • Lipids in Health and Disease, March 2022, Springer Science + Business Media

    Gaetano Santulli

  81. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

    Article • Diabetes Care, March 2022, American Diabetes Association

    Gaetano Santulli

  82. Functional Role of microRNAs in Regulating Cardiomyocyte Death

    Article • Cells, March 2022, MDPI AG

    Gaetano Santulli

  83. Global cognitive function correlates with P‐wave dispersion in frail hypertensive older adults

    Article • Journal of Clinical Hypertension, March 2022, Wiley

    Gaetano Santulli

  84. Exosome-Mediated Angiogenesis Underlies LVAD-Induced Bleeding in Patients With End-Stage Heart Failure

    Article • JACC Basic to Translational Science, March 2022, Elsevier

    Gaetano Santulli

  85. Tirzepatide versus Semaglutide Once Weekly in Type 2 Diabetes

    Article • New England Journal of Medicine, February 2022, New England Journal of Medicine (NEJM/MMS)

    Gaetano Santulli

  86. IP3 receptor orchestrates maladaptive vascular responses in heart failure

    Article • Journal of Clinical Investigation, February 2022, American Society for Clinical Investigation

    Gaetano Santulli

  87. Epidemiology of obstructive sleep apnea: What is the contribution of hypertension and arterial stiffness?

    Article • Journal of Clinical Hypertension, February 2022, Wiley

    Gaetano Santulli

  88. Diabetes and restenosis

    Article • Cardiovascular Diabetology, February 2022, Springer Science + Business Media

    Gaetano Santulli

  89. Sortilin drives hypertension by modulating sphingolipid/ceramide homeostasis and by triggering oxidative stress

    Article • Journal of Clinical Investigation, February 2022, American Society for Clinical Investigation

    Gaetano Santulli

  90. In permanent AF with narrow QRS, AV junction ablation + CRT vs. rate-control drug therapy reduced mortality

    Article • Annals of Internal Medicine, February 2022, American College of Physicians

    Gaetano Santulli

  91. Correlation of physical and cognitive impairment in diabetic and hypertensive frail older adults

    Article • Cardiovascular Diabetology, January 2022, Springer Science + Business Media

    Gaetano Santulli

  92. OUP accepted manuscript

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, January 2022, Oxford University Press (OUP)

    Gaetano Santulli

  93. Effects of insulin resistance on mitochondrial (dys)function

    Article • Atherosclerosis, January 2022, Elsevier

    Gaetano Santulli

  94. Heart failure in diabetes

    Article • Metabolism, December 2021, Elsevier

    Gaetano Santulli

  95. Glycation of Ryanodine Receptor in Circulating Lymphocytes Predicts the Response to Cardiac Resynchronization Therapy

    Article • The Journal of Heart and Lung Transplantation, December 2021, Elsevier

    Gaetano Santulli

  96. Aspirin, NOACs, Warfarin: which is the best choice to tackle cognitive decline in elderly patients? Insights from the GIRAF and ASCEND-Dementia trials presented at the AHA 2021

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, November 2021, Oxford University Press (OUP)

    Gaetano Santulli

  97. Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up

    Article • Frontiers in Pharmacology, November 2021, Frontiers

    Gaetano Santulli

  98. l-Arginine and COVID-19: An Update

    Article • Nutrients, November 2021, MDPI AG

    Gaetano Santulli

  99. Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases

    Article • Frontiers in Endocrinology, October 2021, Frontiers

    Gaetano Santulli

  100. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis

    Article • EClinicalMedicine, October 2021, Elsevier

    Gaetano Santulli

  101. Hyperglycemia Drives Stent Restenosis in STEMI Patients

    Article • Diabetes Care, September 2021, American Diabetes Association

    Gaetano Santulli

  102. The Non-Coding RNA Journal Club: Highlights on Recent Papers—9

    Article • Non-Coding RNA, September 2021, MDPI AG

    Gaetano Santulli

  103. Advances in the understanding of excitation-contraction coupling: the pulsing quest for drugs against heart failure and arrhythmias

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, September 2021, Oxford University Press (OUP)

    Gaetano Santulli

  104. Role of endothelial miR-24 in COVID-19 cerebrovascular events

    Article • Critical Care, August 2021, Springer Science + Business Media

    Gaetano Santulli

  105. Cognitive Impairment in Frail Hypertensive Elderly Patients: Role of Hyperglycemia

    Article • Cells, August 2021, MDPI AG

    Gaetano Santulli

  106. A Retinoic Acid Receptorβ2Agonist Improves Cardiac Function in a Heart Failure Model

    Article • Journal of Pharmacology and Experimental Therapeutics, August 2021, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Gaetano Santulli

  107. Functional Role of miR-155 in the Pathogenesis of Diabetes Mellitus and Its Complications

    Article • Non-Coding RNA, July 2021, MDPI AG

    Gaetano Santulli

  108. Cognitive dysfunction correlates with physical impairment in frail patients with acute myocardial infarction

    Article • Aging Clinical and Experimental Research, June 2021, Springer Science + Business Media

    Gaetano Santulli

  109. SGLT2 inhibitors in cardiovascular medicine

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, May 2021, Oxford University Press (OUP)

    Gaetano Santulli

  110. Targeting the phenotypic switch of vascular smooth muscle cells to tackle atherosclerosis

    Article • Atherosclerosis, May 2021, Elsevier

    Gaetano Santulli

  111. Editorial: Mitochondrial Remodeling and Dynamic Inter-Organellar Contacts in Cardiovascular Physiopathology

    Article • Frontiers in Cell and Developmental Biology, April 2021, Frontiers

    Gaetano Santulli

  112. Impact of thrombus aspiration in frail STEMI patients

    Article • Aging Clinical and Experimental Research, April 2021, Springer Science + Business Media

    Gaetano Santulli

  113. Effects of Chronic Supplementation of L-Arginine on Physical Fitness in Water Polo Players

    Article • Oxidative Medicine and Cellular Longevity, March 2021, Hindawi Publishing Corporation

    Gaetano Santulli

  114. Inclisiran: a new milestone on the PCSK9 road to tackle cardiovascular risk

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, February 2021, Oxford University Press (OUP)

    Gaetano Santulli

  115. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells

    Article • Non-Coding RNA, February 2021, MDPI AG

    Gaetano Santulli

  116. miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations

    Article • February 2021, Research Square

    Gaetano Santulli

  117. Chronic kidney disease: Definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk

    Article • Journal of Clinical Hypertension, January 2021, Wiley

    Gaetano Santulli

  118. The discovery and development of IP3 receptor modulators: an update

    Article • Expert Opinion on Drug Discovery, January 2021, Taylor & Francis

    Gaetano Santulli

  119. In patients with early AF and CV conditions, early rhythm-control therapy vs. usual care reduced CV events at 5 years

    Article • Annals of Internal Medicine, January 2021, American College of Physicians

    Gaetano Santulli

  120. What is linking COVID-19 and endothelial dysfunction? Updates on nanomedicine and bioengineering from the 2020 AHA Scientific Sessions

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, December 2020, Oxford University Press (OUP)

    Gaetano Santulli

  121. Thyroid hormones regulate both cardiovascular and renal mechanisms underlying hypertension

    Article • Journal of Clinical Hypertension, December 2020, Wiley

    Gaetano Santulli

  122. Vitamin C and Cardiovascular Disease: An Update

    Article • Antioxidants, December 2020, MDPI AG

    Gaetano Santulli

  123. Exploiting GRK2 Inhibition as a Therapeutic Option in Experimental Cancer Treatment: Role of p53-Induced Mitochondrial Apoptosis

    Article • Cancers, November 2020, MDPI AG

    Gaetano Santulli

  124. miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19

    Article • Biomedicines, October 2020, MDPI AG

    Gaetano Santulli

  125. Genetics of adrenergic signaling drives coronary artery calcification

    Article • Atherosclerosis, October 2020, Elsevier

    Gaetano Santulli

  126. Metabolic Flexibility of Mitochondria Plays a Key Role in Balancing Glucose and Fatty Acid Metabolism in the Diabetic Heart

    Article • Diabetes, September 2020, American Diabetes Association

    Gaetano Santulli

  127. Role of Endothelial G Protein-Coupled Receptor Kinase 2 in Angioedema

    Article • Hypertension, September 2020, Wolters Kluwer Health

    Gaetano Santulli

  128. Implications of AB0 blood group in hypertensive patients with covid-19

    Article • BMC Cardiovascular Disorders, August 2020, Springer Science + Business Media

    Gaetano Santulli

  129. Arginine and Endothelial Function

    Article • Biomedicines, August 2020, MDPI AG

    Gaetano Santulli

  130. miR-7 Regulates GLP-1-Mediated Insulin Release by Targeting β-Arrestin 1

    Article • Cells, July 2020, MDPI AG

    Gaetano Santulli

  131. No pleotropic effects of linagliptin on atherosclerotic plaques: Case closed

    Article • Atherosclerosis, July 2020, Elsevier

    Gaetano Santulli

  132. Standardizing translational microbiome studies and metagenomic analyses

    Article • Cardiovascular Research, June 2020, Oxford University Press (OUP)

    Gaetano Santulli

  133. Exosomal microRNAs Drive Thrombosis in COVID-19

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Gaetano Santulli

  134. Cardiac BIN1 Replacement Therapy Ameliorates Inotropy and Lusitropy in Heart Failure by Regulating Calcium Handling

    Article • JACC Basic to Translational Science, June 2020, Elsevier

    Gaetano Santulli

  135. In acute HF, intensive and sustained vasodilation did not reduce a composite of death or HF readmission at 180 days

    Article • Annals of Internal Medicine, May 2020, American College of Physicians

    Gaetano Santulli

  136. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence

    Article • Journal of Clinical Medicine, May 2020, MDPI AG

    Gaetano Santulli

  137. A Special Thanks to the Reviewers of Diabetes

    Article • Diabetes, April 2020, American Diabetes Association

    Daniel Moore, Gaetano Santulli

  138. Is COVID-19 an Endothelial Disease? Clinical and Basic Evidence

    Article • April 2020, MDPI AG

    Gaetano Santulli

  139. Inositol 1,4,5-Trisphosphate Receptors in Human Disease: A Comprehensive Update

    Article • Journal of Clinical Medicine, April 2020, MDPI AG

    Gaetano Santulli

  140. A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy

    Article • Nature Cancer, March 2020, Springer Science + Business Media

    Gaetano Santulli

  141. Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study

    Article • Journal of Clinical Medicine, February 2020, MDPI AG

    Gaetano Santulli

  142. Cardiomyocyte‐derived exosomal microRNA‐92a mediates post‐ischemic myofibroblast activation both in vitro and ex vivo

    Article • ESC Heart Failure, January 2020, Wiley

    Gaetano Santulli

  143. Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study

    Article • January 2020, MDPI AG

    Gaetano Santulli

  144. In AF and stable CAD, rivaroxaban reduced cardiovascular events and mortality more than rivaroxaban plus an antiplatelet

    Article • Annals of Internal Medicine, January 2020, American College of Physicians

    Gaetano Santulli

  145. Pathophysiological mechanisms underlying the beneficial effects of physical activity in hypertension

    Article • Journal of Clinical Hypertension, January 2020, Wiley

    Gaetano Santulli

  146. Calcium supplements: Good for the bone, bad for the heart? A systematic updated appraisal

    Article • Atherosclerosis, January 2020, Elsevier

    Gaetano Santulli

  147. Cardiosomal microRNAs Are Essential in Post-Infarction Myofibroblast Phenoconversion

    Article • International Journal of Molecular Sciences, December 2019, MDPI AG

    Gaetano Santulli

  148. Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders

    Article • Expert Opinion on Therapeutic Targets, December 2019, Taylor & Francis

    Gaetano Santulli

  149. We are What We Eat: Impact of Food from Short Supply Chain on Metabolic Syndrome

    Article • Journal of Clinical Medicine, November 2019, MDPI AG

    Gaetano Santulli

  150. In type 2 diabetes, intensive glucose control for 5.6 years did not differ from usual care for major CV events at 14 years

    Article • Annals of Internal Medicine, September 2019, American College of Physicians

    Gaetano Santulli

  151. Catheter ablation improved quality of life more than drug therapy at 1 y in symptomatic atrial fibrillation

    Article • Annals of Internal Medicine, July 2019, American College of Physicians

    Gaetano Santulli

  152. Catheter ablation did not reduce CV events and mortality more than drug therapy in symptomatic AF

    Article • Annals of Internal Medicine, July 2019, American College of Physicians

    Gaetano Santulli

  153. Pre-eclampsia and future cardiovascular diseases: How to assess the risk?

    Article • Atherosclerosis, July 2019, Elsevier

    Gaetano Santulli

  154. Functional role of gut microbiota and PCSK9 in the pathogenesis of diabetes mellitus and cardiovascular disease

    Article • Atherosclerosis, July 2019, Elsevier

    Gaetano Santulli

  155. The Non-Coding RNA Journal Club: Highlights on Recent Papers—7

    Article • Non-Coding RNA, June 2019, MDPI AG

    Gaetano Santulli

  156. Diabetes Mellitus and Its Cardiovascular Complications: New Insights into an Old Disease

    Article • Journal of Diabetes Research, May 2019, Hindawi Publishing Corporation

    Gaetano Santulli, Claudio de Lucia, Celestino Sardu

  157. Editorial: Cardiovascular Disease and Diabetes

    Article • Frontiers in Endocrinology, May 2019, Frontiers

    Gaetano Santulli

  158. Heparanase in health and disease: The neglected housekeeper of the cell?

    Article • Atherosclerosis, April 2019, Elsevier

    Gaetano Santulli

  159. Why is chronic obstructive pulmonary disease linked to atrial fibrillation? A systematic overview of the underlying mechanisms

    Article • International Journal of Cardiology, February 2019, Elsevier

    Gaetano Santulli

  160. Safety in numbers: Identifying multiple targets for beta cell proliferation

    Article • Science Translational Medicine, January 2019, American Association for the Advancement of Science

    Gaetano Santulli

  161. In diabetes with no CVD, aspirin reduced serious vascular events but increased major bleeding at 7.4 years

    Article • Annals of Internal Medicine, December 2018, American College of Physicians

    Gaetano Santulli

  162. Diabetes, body fat, skeletal muscle, and hypertension: The ominous chiasmus?

    Article • Journal of Clinical Hypertension, December 2018, Wiley

    Gaetano Santulli

  163. Exosomal microRNA: The revolutionary endogenous Innerspace nanotechnology

    Article • Science Translational Medicine, November 2018, American Association for the Advancement of Science

    Gaetano Santulli

  164. The Impact of Obesity on the Cardiovascular System

    Article • Journal of Diabetes Research, November 2018, Hindawi Publishing Corporation

    Gaetano Santulli

  165. Stroke prevention: Learning from the master (and COMMANDER)

    Article • Science Translational Medicine, September 2018, American Association for the Advancement of Science

    Gaetano Santulli

  166. The Non-Coding RNA Journal Club: Highlights on Recent Papers—6

    Article • Non-Coding RNA, September 2018, MDPI AG

    Gaetano Santulli

  167. Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure

    Article • Circulation, September 2018, Wolters Kluwer Health

    Gaetano Santulli

  168. Update on peripheral artery disease: Epidemiology and evidence-based facts

    Article • Atherosclerosis, August 2018, Elsevier

    Gaetano Santulli

  169. The lymphatic border patrol outwits inflammatory cells in myocardial infarction

    Article • Science Translational Medicine, July 2018, American Association for the Advancement of Science

    Gaetano Santulli

  170. Cardioprotective effects of autophagy: Eat your heart out, heart failure!

    Article • Science Translational Medicine, May 2018, American Association for the Advancement of Science

    Gaetano Santulli

  171. Direct Small Molecule Activation of Mitofusins

    Article • April 2018, Cold Spring Harbor Laboratory Press

    Gaetano Santulli

  172. Overlooking cardiac dysfunction triggered by immune checkpoint inhibitors: Caution, trespassers will be ventilated

    Article • Science Translational Medicine, April 2018, American Association for the Advancement of Science

    Gaetano Santulli

  173. Dietary fat is a key determinant in balancing mitochondrial dynamics in heart failure: a novel mechanism underlying the obesity paradox

    Article • Cardiovascular Research, March 2018, Oxford University Press (OUP)

    Gaetano Santulli

  174. The Amino-Terminal Domain of GRK5 Inhibits Cardiac Hypertrophy through the Regulation of Calcium-Calmodulin Dependent Transcription Factors

    Article • International Journal of Molecular Sciences, March 2018, MDPI AG

    Gaetano Santulli

  175. Effectiveness of new generation drug-eluting stents in ostial right coronary artery lesions

    Article • International Journal of Cardiology, March 2018, Elsevier

    Gaetano Santulli

  176. Endothelial cells: The heart attack of the clones

    Article • Science Translational Medicine, February 2018, American Association for the Advancement of Science

    Gaetano Santulli

  177. Ryanodine Receptor Structure and Function in Health and Disease

    Article • January 2018, Springer Science + Business Media

    Gaetano Santulli

  178. Sirolimus induces depletion of intracellular calcium stores and mitochondrial dysfunction in pancreatic beta cells

    Article • Scientific Reports, November 2017, Springer Science + Business Media

    Gaetano Santulli

  179. Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure

    Article • Cell Communication and Signaling, November 2017, Springer Science + Business Media

    Gaetano Santulli

  180. Opposite effects of β 2 -adrenoceptor gene deletion on insulin signaling in liver and skeletal muscle

    Article • Nutrition Metabolism and Cardiovascular Diseases, July 2017, Elsevier

    Gaetano Santulli

  181. Physiology and pathophysiology of excitation–contraction coupling: the functional role of ryanodine receptor

    Article • Journal of Muscle Research and Cell Motility, June 2017, Springer Science + Business Media

    Gaetano Santulli

  182. The Non-Coding RNA Journal Club: Highlights on Recent Papers—5

    Article • Non-Coding RNA, June 2017, MDPI AG

    Gaetano Santulli

  183. Intracellular calcium release channels: an update

    Article • The Journal of Physiology, May 2017, Wiley

    Gaetano Santulli

  184. Effects of Alpha Lipoic Acid on Multiple Cytokines and Biomarkers and Recurrence of Atrial Fibrillation Within 1 Year of Catheter Ablation

    Article • The American Journal of Cardiology, May 2017, Elsevier

    Gaetano Santulli

  185. Quit smoking to outsmart atherogenesis: Molecular mechanisms underlying clinical evidence

    Article • Atherosclerosis, February 2017, Elsevier

    Gaetano Santulli

  186. Mechanistic Role of Kinases in the Regulation of Mitochondrial Fitness

    Article • January 2017, Springer Science + Business Media

    Gaetano Santulli

  187. Functional Role of Mitochondria in Arrhythmogenesis

    Article • January 2017, Springer Science + Business Media

    Gaetano Santulli

  188. New Insights in Cardiac Calcium Handling and Excitation-Contraction Coupling

    Article • January 2017, Springer Science + Business Media

    Gaetano Santulli

  189. Childhood obesity and education

    Article • The Lancet Diabetes & Endocrinology, November 2016, Elsevier

    Gaetano Santulli

  190. Adrenergic signaling in heart failure and cardiovascular aging

    Article • Maturitas, November 2016, Elsevier

    Gaetano Santulli

  191. Dietary Components and Metabolic Dysfunction: Translating Preclinical Studies into Clinical Practice

    Article • Nutrients, October 2016, MDPI AG

    Gaetano Santulli

  192. Integrating diet and inflammation to calculate cardiovascular risk

    Article • Atherosclerosis, October 2016, Elsevier

    Gaetano Santulli

  193. Erratum: The Non-Coding RNA Journal Club: Highlights on Recent Papers—4. Non-Coding RNA 2016, 2, 9

    Article • Non-Coding RNA, September 2016, MDPI AG

    Gaetano Santulli

  194. The Non-Coding RNA Journal Club: Highlights on Recent Papers—4

    Article • Non-Coding RNA, September 2016, MDPI AG

    Gaetano Santulli

  195. Leaky ryanodine receptors contribute to diaphragmatic weakness during mechanical ventilation

    Article • Proceedings of the National Academy of Sciences, July 2016, Proceedings of the National Academy of Sciences

    Gaetano Santulli

  196. Maintenance of normal blood pressure is dependent on IP3R1-mediated regulation of eNOS

    Article • Proceedings of the National Academy of Sciences, July 2016, Proceedings of the National Academy of Sciences

    Gaetano Santulli

  197. Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study

    Article • International Journal of Clinical Practice, June 2016, Wiley

    Gaetano Santulli

  198. The possible role of chromosome X variability in hypertensive familiarity

    Article • Journal of Human Hypertension, February 2016, Nature

    Natalia V Rivera, Gaetano Santulli

  199. MicroRNAs and Endothelial (Dys) Function

    Article • Journal of Cellular Physiology, December 2015, Wiley

    Gaetano Santulli

  200. The Non-Coding RNA Journal Club: Highlights on Recent Papers—3

    Article • Non-Coding RNA, December 2015, MDPI AG

    Gaetano Santulli

  201. GRK2 induces cardiac hypertrophy through the regulation of NFκB activity

    Article • Vascular Pharmacology, December 2015, Elsevier

    Gaetano Santulli

  202. Calcium release channel RyR2 regulates insulin release and glucose homeostasis

    Article • Journal of Clinical Investigation, November 2015, American Society for Clinical Investigation

    Gaetano Santulli

  203. A conversation with Helen Hobbs

    Article • Journal of Clinical Investigation, November 2015, American Society for Clinical Investigation

    Gaetano Santulli

  204. Review of "Phosphoinositide 3-kinase: friend and foe in cardiovascular disease"

    Article • September 2015, Publons

    Gaetano Santulli

  205. Review of "Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy"

    Article • September 2015, Publons

    Gaetano Santulli

  206. Review of "KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways"

    Article • September 2015, Publons

    Gaetano Santulli

  207. The Non-Coding RNA Journal Club: Highlights on Recent Papers—2

    Article • Non-Coding RNA, September 2015, MDPI AG

    Gaetano Santulli

  208. Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging

    Article • Current Molecular Pharmacology, September 2015, Bentham Science Publishers

    Gaetano Santulli

  209. Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy

    Article • Journal of Cardiovascular Translational Research, July 2015, Springer Science + Business Media

    Gaetano Santulli

  210. Mitochondrial calcium overload is a key determinant in heart failure

    Article • Proceedings of the National Academy of Sciences, July 2015, Proceedings of the National Academy of Sciences

    Gaetano Santulli

  211. Mitochondrial oxidative stress promotes atrial fibrillation

    Article • Scientific Reports, July 2015, Nature

    Gaetano Santulli

  212. Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy

    Article • PLoS ONE, June 2015, PLOS

    Gaetano Santulli

  213. The Non-Coding RNA Journal Club: Highlights on Recent Papers

    Article • Non-Coding RNA, June 2015, MDPI AG

    Gaetano Santulli

  214. Calcium release channel RyR2 regulates insulin release and glucose homeostasis

    Article • Journal of Clinical Investigation, April 2015, American Society for Clinical Investigation

    Gaetano Santulli

  215. β-Blockers in Diabetic Patients With Heart Failure

    Article • JAMA Internal Medicine, April 2015, American Medical Association (AMA)

    Gaetano Santulli

  216. Effects of Low-Carbohydrate and Low-Fat Diets

    Article • Annals of Internal Medicine, March 2015, American College of Physicians

    Gaetano Santulli

  217. A Fleeting Glimpse Inside microRNA, Epigenetics, and Micropeptidomics

    Article • January 2015, Springer Science + Business Media

    Gaetano Santulli

  218. Exploiting microRNA Specificity and Selectivity: Paving a Sustainable Path Towards Precision Medicine

    Article • January 2015, Springer Science + Business Media

    Gaetano Santulli

  219. microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis

    Article • January 2015, Springer Science + Business Media

    Gaetano Santulli

  220. Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis

    Article • January 2015, Springer Science + Business Media

    Gaetano Santulli

  221. Circulating microRNAs: The Future of Biomarkers in Anti-doping Field

    Article • January 2015, Springer Science + Business Media

    Gaetano Santulli

  222. Computational Prediction of microRNA Targets

    Article • January 2015, Springer Science + Business Media

    Gaetano Santulli

  223. Essential Role of microRNA in Skin Physiology and Disease

    Article • January 2015, Springer Science + Business Media

    Gaetano Santulli

  224. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy

    Article • January 2015, Springer Science + Business Media

    Gaetano Santulli

  225. microRNA: Basic Science

    Article • January 2015, Springer Science + Business Media

    Gaetano Santulli

  226. microRNA: Cancer

    Article • January 2015, Springer Science + Business Media

    Gaetano Santulli

  227. microRNA: Medical Evidence

    Article • January 2015, Springer Science + Business Media

    Gaetano Santulli

  228. Functional Role of Calstabin2 in Age-related Cardiac Alterations

    Article • Scientific Reports, December 2014, Nature

    Gaetano Santulli

  229. Metabolic syndrome is associated with a poor outcome in patients affected by outflow tract premature ventricular contractions treated by catheter ablation

    Article • BMC Cardiovascular Disorders, December 2014, Springer Science + Business Media

    Dr Vasileios Kamperidis, Gaetano Santulli

  230. Application of microRNAs in diagnosis and treatment of cardiovascular disease

    Article • Acta Physiologica, November 2014, Wiley

    Gaetano Santulli

  231. Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging

    Article • Proceedings of the National Academy of Sciences, October 2014, Proceedings of the National Academy of Sciences

    Gaetano Santulli

  232. CaMKII protects MKP-1 from proteasome degradation in endothelial cells

    Article • Cellular Signalling, October 2014, Elsevier

    Gaetano Santulli

  233. A selective microRNA-based strategy inhibits restenosis while preserving endothelial function

    Article • Journal of Clinical Investigation, August 2014, American Society for Clinical Investigation

    Gaetano Santulli

  234. Chest Pain, Panic Disorder and Coronary Artery Disease: A Systematic Review

    Article • CNS & Neurological Disorders - Drug Targets, June 2014, Bentham Science Publishers

    Gaetano Santulli

  235. Functional role of miRNA in cardiac resynchronization therapy

    Article • Pharmacogenomics, June 2014, Future Medicine

    Professor raffaele marfella, Gaetano Santulli

  236. Impact of Diabetes Mellitus on the Clinical Response to Cardiac Resynchronization Therapy in Elderly People

    Article • Journal of Cardiovascular Translational Research, February 2014, Springer Science + Business Media

    Professor raffaele marfella, Gaetano Santulli

  237. Atrial fibrillation and microRNAs

    Article • Frontiers in Physiology, January 2014, Frontiers

    Gaetano Santulli

  238. Angiopoietin-Like Proteins: A Comprehensive Look

    Article • Frontiers in Endocrinology, January 2014, Frontiers

    Gaetano Santulli

  239. Myocardial Perfusion Imaging Study of CO2-Induced Panic Attack

    Article • The American Journal of Cardiology, January 2014, Elsevier

    Gaetano Santulli

  240. Adrenal Signaling in Heart Failure: Something More Than a Distant Ship's Smoke on the Horizon

    Article • Hypertension, November 2013, Wolters Kluwer Health

    Gaetano Santulli

  241. Imaging atrial arrhythmic intracellular calcium in intact heart

    Article • Journal of Molecular and Cellular Cardiology, November 2013, Elsevier

    Gaetano Santulli

  242. Tailoring mTOR-based therapy: molecular evidence and clinical challenges

    Article • Pharmacogenomics, September 2013, Future Medicine

    Gaetano Santulli

  243. G-Protein-Coupled Receptor Kinase 2 and Hypertension

    Article • High Blood Pressure & Cardiovascular Prevention, March 2013, Springer Science + Business Media

    Gaetano Santulli

  244. Adrenergic receptors and metabolism: role in development of cardiovascular disease

    Article • Frontiers in Physiology, January 2013, Frontiers

    Gaetano Santulli

  245. Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the β adrenergic system

    Article • Frontiers in Physiology, January 2013, Frontiers

    Gaetano Santulli

  246. Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes

    Article • Immunity & Ageing, January 2013, Springer Science + Business Media

    Gaetano Santulli

  247. CaMK4 Gene Deletion Induces Hypertension

    Article • Journal of the American Heart Association, August 2012, Wolters Kluwer Health

    Gaetano Santulli

  248. Endothelial Cells Are Able to Synthesize and Release Catecholamines Both In Vitro and In Vivo

    Article • Hypertension, June 2012, Wolters Kluwer Health

    Gaetano Santulli

  249. Role of cardiac resynchronization therapy in the development of new-onset atrial fibrillation: A single-center prospective study.

    Article • Nature Reports Climate Change, April 2012, Nature

    Gaetano Santulli

  250. Role of cardiac resynchronization therapy in the development of new-onset atrial fibrillation: A single-center prospective study.

    Article • Nature Reports Climate Change, April 2012, Nature

    Gaetano Santulli

  251. Regarding the impact of left ventricular size on response to cardiac resynchronization therapy

    Article • American Heart Journal, April 2012, Elsevier

    Gaetano Santulli

  252. Coronary Heart Disease Risk Factors and Mortality

    Article • JAMA, March 2012, American Medical Association (AMA)

    Gaetano Santulli

  253. Thrombolysis Outcomes in Acute Ischemic Stroke Patients With Prior Stroke and Diabetes Mellitu

    Article • Neurology, March 2012, Wolters Kluwer Health

    Gaetano Santulli

  254. Development of Atrial Fibrillation in Recipients of Cardiac Resynchronization Therapy: The Role of Atrial Reverse Remodelling

    Article • Canadian Journal of Cardiology, March 2012, Elsevier

    Gaetano Santulli

  255. Atrial remodelling in echocardiographic super-responders to cardiac resynchronization therapy

    Article • Heart, February 2012, BMJ

    Gaetano Santulli

  256. Age-Related Impairment in Insulin Release: The Essential Role of  2-Adrenergic Receptor

    Article • Diabetes, February 2012, American Diabetes Association

    Gaetano Santulli

  257. Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis

    Article • Cellular Signalling, February 2012, Elsevier

    Gaetano Santulli

  258. Atrial Function in Patients Undergoing CRT

    Article • JACC Cardiovascular Imaging, January 2012, Elsevier

    Gaetano Santulli

  259. Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated cardiomyopathy

    Article • International Journal of Clinical Practice, October 2011, Wiley

    Gaetano Santulli

  260. In patients affected by nonischemic dilated cardiomyopathy, cardiac resynchronization therapy response predicts occurrence of atrial fibrillation

    Article • Cardiovascular Revascularization Medicine, May 2011, Elsevier

    Gaetano Santulli

  261. G Protein-Coupled Receptor Kinase 2 in Patients With Acute Myocardial Infarction

    Article • The American Journal of Cardiology, April 2011, Elsevier

    Gaetano Santulli, Dr Alfonso Campanile

  262. Integrating Cardiac PIP3 and cAMP Signaling through a PKA Anchoring Function of p110γ

    Article • Molecular Cell, April 2011, Elsevier

    Gaetano Santulli

  263. Impaired neoangiogenesis in β2-adrenoceptor gene-deficient mice: restoration by intravascular human β2-adrenoceptor gene transfer and role of NFκB and CREB transcription factors

    Article • British Journal of Pharmacology, January 2011, Wiley

    Gaetano Santulli

  264. Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit

    Article • Journal of Translational Medicine, January 2011, Springer Science + Business Media

    Gaetano Santulli

  265. The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events

    Article • BMC Cardiovascular Disorders, September 2010, Springer Science + Business Media

    Gaetano Santulli

  266. Intracardiac Injection of AdGRK5-NT Reduces Left Ventricular Hypertrophy by Inhibiting NF- B-Dependent Hypertrophic Gene Expression

    Article • Hypertension, July 2010, Wolters Kluwer Health

    Gaetano Santulli

  267. Advanced algorithms can lead to electrocardiographic misinterpretations

    Article • International Journal of Cardiology, May 2010, Elsevier

    Gaetano Santulli

  268. Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-β activity and TGF-β1 expression

    Article • Diabetologia, September 2009, Springer Science + Business Media

    Gaetano Santulli

  269. The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance

    Article • Cardiovascular Research, July 2009, European Society of Cardiology

    Gaetano Santulli, Dr Alfonso Campanile

  270. In vivo properties of the proangiogenic peptide QK

    Article • Journal of Translational Medicine, June 2009, Springer Science + Business Media

    Gaetano Santulli, Dr Alfonso Campanile

  271. Endothelial α1-adrenoceptors regulate neo-angiogenesis

    Article • British Journal of Pharmacology, January 2009, Wiley

    Gaetano Santulli, Dr Alfonso Campanile

  272. A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFκB activity

    Article • Molecular Cancer, January 2009, Springer Science + Business Media

    Gaetano Santulli, Dr Alfonso Campanile

  273. Enhanced GRK2 Expression and Desensitization of βAR Vasodilatation in Hypertensive Patients

    Article • Clinical and Translational Science, November 2008, Wiley

    Gaetano Santulli, Dr Alfonso Campanile

  274. The G-protein-coupled receptor kinase 5 inhibits NFκB transcriptional activity by inducing nuclear accumulation of IκBα

    Article • Proceedings of the National Academy of Sciences, November 2008, Proceedings of the National Academy of Sciences

    Gaetano Santulli, Dr Alfonso Campanile

  275. Endothelial β2 adrenergic signaling to AKT: Role of Gi and SRC

    Article • Cellular Signalling, September 2007, Elsevier

    Gaetano Santulli, Dr Alfonso Campanile

  276. G protein-coupled receptor kinases 2 (GRK2) and acute myocardial infarction

    Article • Journal of Molecular and Cellular Cardiology, June 2007, Elsevier

    Gaetano Santulli

  277. GRK5 regulates NFkB transcription activity in endothelial cells

    Article • Journal of Molecular and Cellular Cardiology, June 2007, Elsevier

    Gaetano Santulli

  278. The PlA1/A2 polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients

    Article • Journal of Hypertension, March 2007, Wolters Kluwer Health

    Gaetano Santulli, Massimo Volpe

  279. G Protein-Coupled Receptor Kinases and Hypertension

    Article • High Blood Pressure & Cardiovascular Prevention, January 2006, Springer Science + Business Media

    Gaetano Santulli, Dr Alfonso Campanile

  280. Ischemic Neoangiogenesis Enhanced by  2-Adrenergic Receptor Overexpression: A Novel Role for the Endothelial Adrenergic System

    Article • Circulation Research, November 2005, Wolters Kluwer Health

    Gaetano Santulli, Dr Alfonso Campanile

  281. AKT Participates in Endothelial Dysfunction in Hypertension

    Article • Circulation, June 2004, Wolters Kluwer Health

    Gaetano Santulli, Dr Alfonso Campanile